MALIGNANT TUMOR
Clinical trials for MALIGNANT TUMOR explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT TUMOR trials appear
Sign up with your email to follow new studies for MALIGNANT TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Inner strength boosts morale in elderly cancer patients
Symptom relief CompletedThis study tested a one-month program designed to build inner strength in elderly cancer patients who were feeling demoralized. 66 patients took part, with half receiving the program plus standard care and the other half receiving standard care alone. The goal was to see if the p…
Matched conditions: MALIGNANT TUMOR
Phase: NA • Sponsor: Peking Union Medical College Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Laser acupuncture may ease chemo sickness in kids
Symptom relief CompletedThis study tested whether using a low-frequency laser on an acupuncture point (P6) can help prevent nausea and vomiting caused by chemotherapy in children aged 2 to 20. The 30 participants received the laser treatment alongside standard anti-nausea drugs. The goal was to see if a…
Matched conditions: MALIGNANT TUMOR
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Your tongue could reveal cancer: AI study analyzes 4,100 people
Knowledge-focused CompletedThis completed study collected tongue images and clinical data from 4,100 people—both cancer patients and healthy individuals—to build a database. Researchers plan to use artificial intelligence to analyze tongue features for early cancer screening and diagnosis. The study did no…
Matched conditions: MALIGNANT TUMOR
Sponsor: Zhejiang Cancer Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Do vaccines work as well in people with weak immune systems? new study investigates
Knowledge-focused CompletedThis study looked at how well the Pfizer COVID-19 vaccine triggers an immune response in 196 adults with weakened immune systems (due to conditions like kidney transplant, cancer, or HIV) compared to healthy adults. Researchers measured antibody levels and their ability to neutra…
Matched conditions: MALIGNANT TUMOR
Phase: PHASE4 • Sponsor: Centre Hospitalier Régional d'Orléans • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC